LYFT vs ORMP
LYFT Inc (LYFT) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.
LYFT Inc (LYFT) is a software - application company listed on US. It is led by David Risher.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
Latest reported LYFT revenue for 2024-12-31 was $5.79B. Net income was $22.8M. Revenue was up 31.4% from 2023-12-31 to 2024-12-31. LYFT currently screens at market cap $6.79B and trailing P/E 107.7.
Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.
LYFT currently screens at market cap $6.79B and trailing P/E 107.7. ORMP currently screens at market cap $87.2M.
Not investment advice. Open the LYFT and ORMP stock pages for the full models.
Not investment advice.